Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (191-200 of 288) with videos related to

Pageof 29
Sort By:
International Journal of Hematology|May 26, 2005
CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 casesTakakazu Kawase, Minoru Hamazaki, Michinori Ogura, et al.
International Journal of Hematology|July 17, 2013
Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 studyHiroki Mizuno, Masashi Sawa, Masamitsu Yanada, et al.
International Journal of Hematology|February 7, 2019
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemiaNahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi, et al.
Cancer Science|May 31, 2017
Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignanciesYosuke Minami, Hironobu Minami, Toshihiro Miyamoto, et al.
Cellular & Molecular Immunology|May 17, 2016
BCR-ABL-specific CD4<sup>+</sup> T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cellsNorihiro Ueda, Rong Zhang, Minako Tatsumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2006
Clinical protocol for angiogenesis by intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe coronary artery disease: TACT-NAGOYA-HEARTHideo Izawa, Takahisa Kondo, Akihiko Usui, et al.
International Journal of Hematology|February 15, 2019
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET systemMasahiro Kizaki, Naoto Takahashi, Noriyoshi Iriyama, et al.
Leukemia Research|June 12, 2012
Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation studyKiyoyuki Ogata, Keiji Kakumoto, Akira Matsuda, et al.
Leukemia Research|September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival ratesMasamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
Cancer Science|February 28, 2012
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 studyKazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, et al.
Pageof 29

Showing results (191-200 of 288) with videos related to

Sort By:
Pageof 29
International Journal of Hematology|May 26, 2005
CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 casesTakakazu Kawase, Minoru Hamazaki, Michinori Ogura, et al.
International Journal of Hematology|July 17, 2013
Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 studyHiroki Mizuno, Masashi Sawa, Masamitsu Yanada, et al.
International Journal of Hematology|February 7, 2019
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemiaNahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi, et al.
Cancer Science|May 31, 2017
Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignanciesYosuke Minami, Hironobu Minami, Toshihiro Miyamoto, et al.
Cellular & Molecular Immunology|May 17, 2016
BCR-ABL-specific CD4<sup>+</sup> T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cellsNorihiro Ueda, Rong Zhang, Minako Tatsumi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2006
Clinical protocol for angiogenesis by intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe coronary artery disease: TACT-NAGOYA-HEARTHideo Izawa, Takahisa Kondo, Akihiko Usui, et al.
International Journal of Hematology|February 15, 2019
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET systemMasahiro Kizaki, Naoto Takahashi, Noriyoshi Iriyama, et al.
Leukemia Research|June 12, 2012
Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation studyKiyoyuki Ogata, Keiji Kakumoto, Akira Matsuda, et al.
Leukemia Research|September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival ratesMasamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
Cancer Science|February 28, 2012
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 studyKazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, et al.
Pageof 29